University Children Hospital, Pediatrics, Gastroenterology and Allergology Department, Medical University of Bialystok, Bialystok, Poland.
University Hospital, Internal Medicine and Rheumatology Department, Medical University of Bialystok, Bialystok, Poland.
Arch Med Sci. 2014 Aug 29;10(4):711-6. doi: 10.5114/aoms.2014.44861.
There are many potential factors that can modulate bronchial reactivity, including exposure to allergens, viral infections, and medications. The aim of this study was to analyze the effect of grass pollination intensity on the bronchial reactivity in seasonal allergic rhinitis (SAR) patients subjected to subcutaneous allergenic immunotherapy (SCIT).
This study, performed between 2005 and 2008, included 41 patients with confirmed sensitivity to grass pollens and predominating symptoms of SAR, randomly assigned to desensitization by pre-seasonal or maintenance SCIT. Bronchial provocation challenge with histamine was performed before the onset of immunotherapy, and repeated three times after each pollen season covered by this study. Bronchial reactivity was analyzed with regard to grass pollination intensity in 2005-2008 (air concentration of grass pollen grains, seasonal number of days when air concentration of grass pollen reached at least 20 or 50 grains per 1 m(3)).
After 3 years of SCIT, a significant decrease in bronchial responsiveness was observed in the analyzed group as confirmed by an increase in PC20 FEV1 histamine values (p = 0.001). An inverse tendency was observed after 2 years of SCIT, however. This second year of SCIT corresponded to the 2007 season, when a significantly higher number of days with at least 50 grains of pollen per 1 m(3) of air was recorded.
FLUCTUATIONS IN POLLINATION INTENSITY OBSERVED DURING CONSECUTIVE YEARS OF IMMUNOTHERAPY CAN INFLUENCE BRONCHIAL REACTIVITY IN PATIENTS SUBJECTED TO SCIT (ISRCTN REGISTER: ISRCTN 86562422).
有许多潜在的因素可以调节支气管反应性,包括暴露于过敏原、病毒感染和药物。本研究的目的是分析草花粉授粉强度对接受皮下过敏原免疫治疗(SCIT)的季节性过敏性鼻炎(SAR)患者支气管反应性的影响。
本研究于 2005 年至 2008 年进行,共纳入 41 例经证实对草花粉敏感且以 SAR 为主诉的患者,随机分为 preseason 或维持期 SCIT 脱敏。在免疫治疗开始前进行组胺支气管激发挑战,并在本研究涵盖的每个花粉季节后重复 3 次。分析 2005-2008 年草花粉授粉强度与支气管反应性的关系(空气中草花粉粒浓度、空气中草花粉浓度至少达到 20 或 50 粒/m³的季节天数)。
SCIT 治疗 3 年后,分析组的支气管反应性显著降低,FEV1 组胺 PC20 值升高(p=0.001)。然而,SCIT 治疗 2 年后观察到相反的趋势。第二年的 SCIT 对应于 2007 年的季节,当时空气中至少有 50 粒花粉/m³的天数明显增加。
在连续几年的免疫治疗期间观察到的授粉强度波动可能会影响接受 SCIT 的患者的支气管反应性(ISRCTN 注册:ISRCTN 86562422)。